Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;19(2):251-260.
doi: 10.1007/s12094-016-1530-0. Epub 2016 Aug 3.

Advanced breast cancer clinical nursing curriculum: review and recommendations

C Vila  1 , C Reñones  2 , T Ferro  3 , Mª Á Peñuelas  4 , M Del Mar Jiménez  5 , Á Rodríguez-Lescure  6 , M Muñoz  7 , R Colomer  8
Affiliations

Advanced breast cancer clinical nursing curriculum: review and recommendations

C Vila et al. Clin Transl Oncol. 2017 Feb.

Abstract

Purpose: The needs and concerns of patients with advanced breast cancer are changing at every phase of the care intervention. Management and coordination of hospital resources and services are also steadily evolving. The objective of the present expert report is to define a new oncology nursing role specialising in advanced breast cancer, to help guide patients throughout the whole healthcare itinerary.

Methods: A group of eight experts in oncology nursing and medical oncology defined the content index of the curriculum document. A systematic review of bibliography was carried out, and the relevant contents were extracted. Based on these contents and the participants' experience, recommendations were formulated and validated through a Delphi questionnaire and a participative meeting.

Results: The advanced breast cancer clinical nurse (ABCCN) should develop a clinical, psychosocial role focused on coordinating patients in the healthcare network. The nurse would be in charge of evaluating and supervising the care administered and the healthcare resources used. The ABCCN should be aware and participate in the protocols and available resources, be able to solve conflicts, deal with burn-out signs and have clinical, coaching and team-working abilities. The proposed curriculum provides a specific process for the care of patients, as well as an implementation process.

Conclusions: The ABCCN's role is crucial to assume the best care and the optimisation of available resources. This review and consensus document provides the required tools for the implementation in hospitals.

Keywords: Breast neoplasms; Case management; Consensus; Counselling; Oncology nursing; Patient navigation.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standardsConflict of interestConcepción Vila declares consultancy work for Novartis Oncology. Concepción Reñones declares consultancy work for Novartis Oncology. Dr. Társila Ferro declares consultancy work for Novartis Oncology. Mª Ángeles Peñuelas declares consultancy work for Novartis Oncology. María del Mar Jiménez declares consultancy work for Novartis Oncology. Dr. Alvaro Rodriguez-Lescure declares no conflict of interest regarding the publication of this paper. Dr. Montserrat Muñoz declares consultancy work for Roche and presenting as a speaker for Celgene and Novartis Oncology. Dr. Ramon Colomer declares no conflict of interest regarding the publication of this paper.

Figures

Fig. 1
Fig. 1
Decision-making and assistance algorithm for advanced breast cancer patients
Fig. 2
Fig. 2
Implementation process of the ABCCN’s position
See this image and copyright information in PMC

References

    1. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol. 2014;15:23–34. doi: 10.1016/S1470-2045(13)70546-1. - DOI - PubMed
    1. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006;56:168–183. doi: 10.3322/canjclin.56.3.168. - DOI - PubMed
    1. Brewster AM, Hortobagyi GN, Broglio KR, Kau SW, Santa-Maria CA, Arun B, et al. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst. 2008;100:1179–1183. doi: 10.1093/jnci/djn233. - DOI - PMC - PubMed
    1. Birchall M, Bailey D, King P. Effect of process standards on survival of patients with head and neck cancer in the south and west of England. Br J Cancer. 2004;91:1477–1481. - PMC - PubMed
    1. Lutterbach J, Pagenstecher A, Spreer J, Hetzel A, Velthoven V, Nikkhah G, et al. The brain tumor board: lessons to be learned from an interdisciplinary conference. Onkologie. 2005;28:22–26. - PubMed

Publication types